These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 32717432)

  • 1. Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee.
    Algwaiz G; Aljurf M; Koh M; Horowitz MM; Ljungman P; Weisdorf D; Saber W; Kodera Y; Szer J; Jawdat D; Wood WA; Brazauskas R; Lehmann L; Pasquini MC; Seber A; Lu PH; Atsuta Y; Riches M; Perales MA; Worel N; Okamoto S; Srivastava A; Chemaly RF; Cordonnier C; Dandoy CE; Wingard JR; Kharfan-Dabaja MA; Hamadani M; Majhail NS; Waghmare AA; Chao N; Kröger N; Shaw B; Mohty M; Niederwieser D; Greinix H; Hashmi SK;
    Biol Blood Marrow Transplant; 2020 Dec; 26(12):2181-2189. PubMed ID: 32717432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 and Hematopoietic Cell Transplantation Center-Specific Survival Analysis: Can We Adjust for the Impact of the Pandemic? Recommendations of the COVID-19 Task Force of the 2020 Center for International Blood and Marrow Transplantation Research Center Outcomes Forum.
    Wingard JR; Ahn KW; Dandoy C; Perales MA; Wood WA; Logan B; Riches M; Rizzo JD
    Transplant Cell Ther; 2021 Jul; 27(7):533-539. PubMed ID: 33895401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in Hematopoietic Cell Transplantation Practices in Response to COVID-19: A Survey from the Worldwide Network for Blood & Marrow Transplantation.
    Worel N; Shaw BE; Aljurf M; Koh M; Seber A; Weisdorf D; Schwartz J; Galeano S; Kodera Y; Eldridge PW; Hashmi S; Atsuta Y; Szer J; Saber W; Niederwieser D; Greinix HT;
    Transplant Cell Ther; 2021 Mar; 27(3):270.e1-270.e6. PubMed ID: 33781537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Recipients.
    Mushtaq MU; Shahzad M; Chaudhary SG; Luder M; Ahmed N; Abdelhakim H; Bansal R; Balusu R; DeJarnette S; Divine C; Kribs R; Shune L; Singh AK; Ganguly S; Abhyankar SH; McGuirk JP
    Transplant Cell Ther; 2021 Sep; 27(9):796.e1-796.e7. PubMed ID: 34256172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for a severe disease course in children with SARS-COV-2 infection following hematopoietic cell transplantation in the pre-Omicron period: a prospective multinational Infectious Disease Working Party from the European Society for Blood and Marrow Transplantation group (EBMT) and the Spanish Group of Hematopoietic Stem Cell Transplantation (GETH) study.
    Averbuch D; de la Camara R; Tridello G; Knelange NS; Bykova TA; Ifversen M; Dobsinska V; Ayas M; Hamidieh AA; Pichler H; Perez-Martinez A; Cesaro S; Sundin M; Badell I; Bader P; Johansson JE; Mirci-Danicar O; Sedlacek P; Paillard C; Gibson B; Lawson S; Kroeger N; Corbacioglu S; Mikulska M; Piñana JL; Styczynski J; Ljungman P
    Bone Marrow Transplant; 2023 May; 58(5):558-566. PubMed ID: 36849806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meeting the Demand for Unrelated Donors in the Midst of the COVID-19 Pandemic: Rapid Adaptations by the National Marrow Donor Program and Its Network Partners Ensured a Safe Supply of Donor Products.
    Auletta JJ; Novakovich JL; Stritesky GL; Newman J; Fridy-Chesser ST; Hailperin K; Devine SM
    Transplant Cell Ther; 2021 Feb; 27(2):133-141. PubMed ID: 33830022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Donor Graft Cryopreservation on Allogeneic Hematopoietic Cell Transplantation Outcomes: A Center for International Blood and Marrow Transplant Research Analysis. Implications during the COVID-19 Pandemic.
    Hsu JW; Farhadfar N; Murthy H; Logan BR; Bo-Subait S; Frey N; Goldstein SC; Horowitz MM; Lazarus H; Schwanke JD; Shah NN; Spellman SR; Switzer GE; Devine SM; Shaw BE; Wingard JR
    Transplant Cell Ther; 2021 Jun; 27(6):507-516. PubMed ID: 33865804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lessons learned from COVID-19 pandemic: outcomes after SARS-CoV-2 infection in hematopoietic cell transplant and cell therapy recipients.
    Al-Ramahi JS; Shahzad M; Li K; DeJarnette S; Chaudhary SG; Lutfi F; Ahmed N; Balusu R; Bansal R; Abdelhakim H; Shune L; Singh AK; Abhyankar SH; McGuirk JP; Mushtaq MU
    Leuk Lymphoma; 2023 Dec; 64(12):1981-1991. PubMed ID: 37574842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serious Stem Cell Donation Events and Recipient Adverse Reactions Related to Severe Acute Respiratory Syndrome Coronavirus 2: Review of Reports to the World Marrow Donor Association.
    Pawson R; Anthias C; Cody M; Fechter M; Fournier D; O'Flaherty E; Oliviera D; van Eerden E; Mengling T
    Transplant Cell Ther; 2023 Aug; 29(8):522.e1-522.e5. PubMed ID: 37271343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the SARS-CoV-2 pandemic on hematopoietic cell transplantation and cellular therapies in Europe 2020: a report from the EBMT activity survey.
    Passweg JR; Baldomero H; Chabannon C; Corbacioglu S; de la Cámara R; Dolstra H; Glass B; Greco R; Mohty M; Neven B; Peffault de Latour R; Perić Z; Snowden JA; Yakoub-Agha I; Sureda A; Kröger N;
    Bone Marrow Transplant; 2022 May; 57(5):742-752. PubMed ID: 35194156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of registries in facilitating clinical research in BMT: examples from the Center for International Blood and Marrow Transplant Research.
    Horowitz M
    Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S1-S2. PubMed ID: 18724277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic cell transplantation program (Part I): Minimum requirements and beyond.
    Pasquini MC; Srivastava A; Ahmed SO; Aljurf M; Atsuta Y; Doleysh C; Galeano S; Gluckman E; Greinix H; Hale G; Hari P; Hashmi SK; Kamani N; Laughlin MJ; Niederwieser D; Seber A; Szer J; Snowden JA; Van Biesen K; Watry P; Weisdorf DJ; Apperley J
    Hematol Oncol Stem Cell Ther; 2020 Sep; 13(3):131-142. PubMed ID: 31449780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, Center for International Blood and Marrow Transplant Research, and the American Society for Blood and Marrow Transplantation (EBMT/CIBMTR/ASBMT).
    Rizzo JD; Wingard JR; Tichelli A; Lee SJ; Van Lint MT; Burns LJ; Davies SM; Ferrara JL; Socié G
    Bone Marrow Transplant; 2006 Feb; 37(3):249-61. PubMed ID: 16435004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody Response to SARS-CoV-2 Vaccination in Patients following Allogeneic Hematopoietic Cell Transplantation.
    Huang A; Cicin-Sain C; Pasin C; Epp S; Audigé A; Müller NJ; Nilsson J; Bankova A; Wolfensberger N; Vilinovszki O; Nair G; Hockl P; Schanz U; Kouyos RD; Hasse B; Zinkernagel AS; Trkola A; Manz MG; Abela IA; Müller AMS
    Transplant Cell Ther; 2022 Apr; 28(4):214.e1-214.e11. PubMed ID: 35092892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic cell transplantation and cellular therapies in Europe 2021. The second year of the SARS-CoV-2 pandemic. A Report from the EBMT Activity Survey.
    Passweg JR; Baldomero H; Ciceri F; Corbacioglu S; de la Cámara R; Dolstra H; Glass B; Greco R; McLornan DP; Neven B; de Latour RP; Perić Z; Ruggeri A; Snowden JA; Sureda A
    Bone Marrow Transplant; 2023 Jun; 58(6):647-658. PubMed ID: 36879108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation.
    Rizzo JD; Wingard JR; Tichelli A; Lee SJ; Van Lint MT; Burns LJ; Davies SM; Ferrara JL; Socié G
    Biol Blood Marrow Transplant; 2006 Feb; 12(2):138-51. PubMed ID: 16443512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurocognitive Dysfunction in Hematopoietic Cell Transplant Recipients: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Complications and Quality of Life Working Party of the European Society for Blood and Marrow Transplantation.
    Kelly DL; Buchbinder D; Duarte RF; Auletta JJ; Bhatt N; Byrne M; DeFilipp Z; Gabriel M; Mahindra A; Norkin M; Schoemans H; Shah AJ; Ahmed I; Atsuta Y; Basak GW; Beattie S; Bhella S; Bredeson C; Bunin N; Dalal J; Daly A; Gajewski J; Gale RP; Galvin J; Hamadani M; Hayashi RJ; Adekola K; Law J; Lee CJ; Liesveld J; Malone AK; Nagler A; Naik S; Nishihori T; Parsons SK; Scherwath A; Schofield HL; Soiffer R; Szer J; Twist I; Warwick A; Wirk BM; Yi J; Battiwalla M; Flowers ME; Savani B; Shaw BE
    Biol Blood Marrow Transplant; 2018 Feb; 24(2):228-241. PubMed ID: 28939455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematopoietic Cell Transplantation: Practice Predictions for the Year 2023.
    Farhadfar N; Burns LJ; Mupfudze T; Shaw BE; Bollard CM; Devine SM; Horowitz MM; Jones RJ; Murthy HS; Wingard JR; Lee SJ
    Transplant Cell Ther; 2021 Feb; 27(2):183.e1-183.e7. PubMed ID: 33045387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Global State of Hematopoietic Cell Transplantation for Multiple Myeloma: An Analysis of the Worldwide Network of Blood and Marrow Transplantation Database and the Global Burden of Disease Study.
    Cowan AJ; Baldomero H; Atsuta Y; Mikhael J; Aljurf M; Seber A; Greinix H; Koh M; Worel N; Libby EN; Pasquini M; Galeano S; Saber W; Iida M; Jaimovich G; Rolon JM; Kodera Y; Benakli M; Nosa BG; Elhaddad A; Szer J; Passweg J; Kroeger N; Weisdorf D; Niederwieser D
    Biol Blood Marrow Transplant; 2020 Dec; 26(12):2372-2377. PubMed ID: 32846200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost and quality issues in establishing hematopoietic cell transplant program in developing countries.
    Hashmi SK; Srivastava A; Rasheed W; Adil S; Wu T; Jagasia M; Nassar A; Hwang WYK; Hamidieh AA; Greinix HT; Pasquini MC; Apperley JF; Aljurf M
    Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):167-172. PubMed ID: 28732192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.